Hypobetalipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 6: | Line 6: | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
| Line 20: | Line 20: | ||
* ''The Merck Manual'', Sec. 2, Ch. 16 | * ''The Merck Manual'', Sec. 2, Ch. 16 | ||
[[pl:Hipobetalipoproteinemia]] | [[pl:Hipobetalipoproteinemia]] | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
{{WH}} | {{WH}} | ||
Revision as of 16:11, 9 August 2012
Template:DiseaseDisorder infobox
Overview
Hypobetalipoproteinemia is a rare genetic disorder causing abnormally low levels of LDL cholesterol. It is thought to be caused by mutated apolipoprotein B. The patient can have hypobetalipoproteinemia and simultaneously have high levels of HDL cholesterol. According to The Merck Manual, "no treatment is required."
Typically in hypobtalipoproteinemia, plasma cholesterol levels will be around 80-120 mg/dL, LDL cholesterol will be around 50-80 mg/dL, and longevity can be expected with good nutrition.
Notably, in people who do NOT have the genetic disorder hypobetalipoproteinemia, a low cholesterol level may be a marker for poor nutrition, wasting disease, cancer, hyperthyroidism, and liver disease.
References
- Young, Stephen G, Hubl, Susan T, Chappell, David A, Smith, Richard S, et al. The New England Journal of Medicine. Boston: Jun 15, 1989. Vol. 320, Iss. 24; pg. 1604
- The Merck Manual, Sec. 2, Ch. 16